cheqfx
Advertisement · 728×90
‹ All stocks
TMCI

Treace Medical Concepts

TMCI · NASDAQ · Healthcare
$4.31
▼ $4.31 (-1.35%)
$4.25 $4.37 $4.50 $4.62 $4.31 Sep 2026 Sep 2026 Oct 2026
Day range
$4.21 – $4.37
Year range
$1.17 – $7.08
Open
$4.37
Previous close
—
Market cap
$279.65M
Volume (24h)
$69.1K
Volume (52w)
$297.99K
Performance
7D
▼ -3.78%
1M
▼ -8.28%
3M
▼ -5.46%
6M
▲ 199.36%
1Y
▼ -31.14%
YTD
▲ 72.43%
3Y
▼ -65.60%
5Y
▼ -82.82%
All-time
▼ -83.11%
Key statistics
P/E ratio
-4.79
EPS (TTM)
$-0.90
Dividend yield
—
Dividend (TTM)
—
Payout ratio
—
Shares outstanding
64.9M
About Treace Medical Concepts

Headquartered in Ponte Vedra Beach, Florida, Treace Medical Concepts, Inc. is an orthopedic medical device enterprise that specializes in the development, manufacturing, and commercialization of surgical tools for foot and ankle specialists throughout the United States. A cornerstone of its product line is the Lapiplasty procedure, which enables surgeons to comprehensively correct bunions in all three dimensions, thereby offering patients significant cosmetic and medical benefits. The firm also provides the Lapiplasty Mini-Incision precision system. Furthermore, its portfolio includes instruments designed to facilitate various ancillary surgical procedures, such as akin osteotomies, weil osteotomies, intercuneiform stabilization, lesser tarsometatarsal joint fusions, autograft bone harvesting, and MTP fusion. Treace Medical Concepts, Inc. was established in 2013.

Visit website
Country: United States of America
More in Healthcare